Details
|
Metabasis is a therapeutics biopharmaceutical company engaging in discovery, producing and commercializing of a small molecule medications indicated for treatment of cancer, metabolic disorders, and other specific disorders linked to the liver's pathways. Metabasis Therapeutics, inc. has 3 products candidates in clinical study such as MB07133- a product indicated for the treatment of liver cancer, which is currently in a phase 1 clinical trial; Pradefovir Mesylate - a drug candidate indicated for the treatment of Hepatitis B; and CS917 drug candidate indicated for the cure of type 2 diabetes. Metabasis Therapeutics, inc., has collaboration with Sicor,inc.; Merck&Co., inc.; Valeant Pharmaceuticals international; and Sankyo company. Metabasis was discovered by John W. Beck, Mark D. Erion, and Paul K. Laikind in 1997. Metabasis Therapeutic, inc. is located in San Diego, state California. Contact www.mbasis.com. Tel: 858-587-2770
|
